Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-26 @ 12:57 AM
NCT ID:
NCT04035434
Group ID:
EG004
Title:
Phase 1: NHL: Cohort A: DL 4a (6x10^8 CAR+ T Cells)
Description:
Participants with NHL received LD chemotherapy consisting of fludarabine (30 mg/m²) and cyclophosphamide (500 mg/m²) administered IV once daily for three consecutive days. LD chemotherapy was completed at least 48 hours, but no more than 7 days, before infusion of CTX110. CTX110 was given as a single IV infusion of 6×10\^8 CAR+ T cells.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
10
Other Number Affected:
10
Other Number At Risk:
10
Study:
NCT04035434
Results Section:
NCT04035434
Adverse Events Module:
NCT04035434